Suzhou Fushilai Pharmaceutical: Announcement on the adjustment of the maximum repurchase price after the implementation of the 2023 annual equity distribution.
Suzhou Fushilai Pharmaceutical: Announcement about the progress of stock repurchase.
Suzhou Fushilai Pharmaceutical: Announcement of Annual Equity Distribution Implementation in 2023
Suzhou Fushilai Pharmaceutical: Announcement on the progress of share repurchases
Fujilai: Announcement on the 2023 Profit Distribution Plan
Fujilai: Announcement on pre-disclosure of some supervisors\' share holdings reduction
Fujilai: Announcement on the progress of share repurchases
Fujilai: Announcement on the initial repurchase of the company's shares and the progress of share repurchases
Fujilai: Repurchase Report
Fujilai: An indicative announcement on receiving proposals from the actual controller, chairman and general manager for the company to repurchase shares
Fujilai: An indicative announcement on the listing and circulation of some issued shares prior to the initial public offering
Fujilai: Announcement on the completion of the implementation of the plan to reduce the shareholdings of supervisors
Fujilai: Announcement on the progress of implementation of the supervisors\' holdings reduction plan and the reduction of more than half of the share holdings
Fujilai: 2022 Annual Equity Distribution Implementation Notice
Fujilai: Announcement on the pre-disclosure of some supervisors' reduced shareholding
Fujilai: Announcement on 2022 Profit Distribution Plan
Fujilai: An indicative announcement on the listing and circulation of the initial public offline placement of restricted shares
Fujilai: Prompt announcement of the listing announcement for the initial public offering of shares and listing on the GEM
Fujilai: Listing announcement for the initial public offering of shares and listing on the GEM
Fujilai: Orient Securities Underwriting Sponsor Co., Ltd.'s listing sponsorship letter for the company's initial public offering of shares and listing on the GEM
No Data